Luis C Maas, Iii

Title: Innovations by Luis C. Maas, III

Introduction

Luis C. Maas, III is an accomplished inventor based in Brookline, MA, with a focus on advancements in the field of mental health. He holds a total of five patents that contribute significantly to the understanding and treatment of attention deficit/hyperactivity disorder (ADHD) and other mental disorders. His innovative approaches aim to enhance patient care through objective assessments and optimized treatment methods.

Latest Patents

One of his latest patents is a "Method for providing optimal drug dosage." This method involves performing an objective ADHD behavioral assay for a patient, administering a drug at varying doses, and conducting an fMRI to determine the optimal dosage for the patient. The process can also include a follow-up ADHD behavioral assay after drug administration. Another notable patent is the "Method and apparatus for detecting mental disorders." This technique computes a T2 relaxation time (RT) to aid in detecting brain dysfunction, including ADHD. It involves obtaining matched axial images and generating a T2 map to identify regions of interest, which are then analyzed to compute the T2 relaxation time.

Career Highlights

Luis C. Maas, III is associated with the McLean Hospital Corporation, where he applies his expertise in mental health research and innovation. His work is pivotal in developing methods that enhance the diagnosis and treatment of mental disorders, particularly ADHD.

Collaborations

He collaborates with notable colleagues such as Perry F. Renshaw and Carl M. Anderson, contributing to a multidisciplinary approach in his research endeavors.

Conclusion

Luis C. Maas, III exemplifies the spirit of innovation in mental health, with his patents paving the way for improved treatment methodologies. His contributions are vital in advancing the understanding and management of ADHD and other mental disorders.